SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Giancarlo Aldini, Giulio Vistoli, Milan Stefek, N. Chondrogianni, Tilman Grune, Jolanta Sereikaite, Izabela Sadowska-Bartosz, Grzegorz Bartosz, Molecular strategies to prevent, inhibit, and degrade advanced glycoxidation and advanced lipoxidation end products, Free Radical Research, 2013, 47, S1, 93

    CrossRef

  2. 2
    R. Nagai, D. B. Murray, T. O. Metz, J. W. Baynes, Chelation: A Fundamental Mechanism of Action of AGE Inhibitors, AGE Breakers, and Other Inhibitors of Diabetes Complications, Diabetes, 2012, 61, 3, 549

    CrossRef

  3. 3
    Zhenzhen Ni, Zhengbing Zhuge, Wenlu Li, Huimin Xu, Zhongmiao Zhang, Haibin Dai, Inhibitory Effects of Hydroxysafflor Yellow A on the Formation of Advanced Glycation End Products in Vitro, Biological and Pharmaceutical Bulletin, 2012, 35, 11, 2050

    CrossRef

  4. 4
    Shinji Hagiwara, Phillip Kantharidis, Mark E. Cooper, What Are New Avenues for Renal Protection, in Addition to RAAS Inhibition?, Current Hypertension Reports, 2012, 14, 2, 100

    CrossRef

  5. 5
    Jie You, Wei Peng, Xu Lin, Qing-Ling Huang, Jian-Yin Lin, PLC/CAMK IV–NF-κB involved in the receptor for advanced glycation end products mediated signaling pathway in human endothelial cells, Molecular and Cellular Endocrinology, 2010, 320, 1-2, 111

    CrossRef

  6. 6
    Faruk Turgut, Warren Kline Bolton, Potential New Therapeutic Agents for Diabetic Kidney Disease, American Journal of Kidney Diseases, 2010, 55, 5, 928

    CrossRef

  7. 7
    N. Grossin, M. Lambert, E. Boulanger, Vaincre la glycation par des approches thérapeutiques, Médecine des Maladies Métaboliques, 2010, 4, 6, 647

    CrossRef

  8. 8
    Hongyan Li, Xuguang Zheng, Hongbo Wang, Yi Zhang, Hongqi Xin, Xiaoguang Chen, XLF-III-43, a novel coumarin–aspirin compound, prevents diabetic nephropathy in rats via inhibiting advanced glycation end products, European Journal of Pharmacology, 2010, 627, 1-3, 340

    CrossRef

  9. 9
    Noriko Yamabe, Ki Sung Kang, Chan Hum Park, Takashi Tanaka, Takako Yokozawa, 7-O-Galloyl-D-sedoheptulose Is a Novel Therapeutic Agent against Oxidative Stress and Advanced Glycation Endproducts in the Diabetic Kidney, Biological & Pharmaceutical Bulletin, 2009, 32, 4, 657

    CrossRef

  10. 10
    J. L. Figarola, S. Loera, Y. Weng, N. Shanmugam, R. Natarajan, S. Rahbar, LR-90 prevents dyslipidaemia and diabetic nephropathy in the Zucker diabetic fatty rat, Diabetologia, 2008, 51, 5, 882

    CrossRef

  11. 11
    Timo M. Buetler, Estelle Leclerc, Alexandra Baumeyer, Helia Latado, John Newell, Oskar Adolfsson, Véronique Parisod, Janique Richoz, Sarah Maurer, Francis Foata, Dominique Piguet, Sylviane Junod, Claus W. Heizmann, Thierry Delatour, Nε-carboxymethyllysine-modified proteins are unable to bind to RAGE and activate an inflammatory response, Molecular Nutrition & Food Research, 2008, 52, 3
  12. 12
    Ki Sung Kang, Noriko Yamabe, Hyun Young Kim, Jeong Hill Park, Takako Yokozawa, Therapeutic potential of 20(S)-ginsenoside Rg3 against streptozotocin-induced diabetic renal damage in rats, European Journal of Pharmacology, 2008, 591, 1-3, 266

    CrossRef

  13. 13
    Samuel Rahbar, Novel inhibitors of glycation and AGE formation, Cell Biochemistry and Biophysics, 2007, 48, 2-3, 147

    CrossRef

  14. 14
    J. Peyroux, M. Sternberg, Advanced glycation endproducts (AGEs): pharmacological inhibition in diabetes, Pathologie Biologie, 2006, 54, 7, 405

    CrossRef

  15. 15
    Current literature in diabetes, Diabetes/Metabolism Research and Reviews, 2006, 22, 4